An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that ...

Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization.

Memorial Sloan Kettering Cancer Center investigators and collaborators have tested rezatapopt, an oral p53 reactivator ...

The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid ...

Researchers at The Jackson Laboratory (JAX), in collaboration with the Massachusetts Institute of Technology (MIT), have ...

Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and ...

What if doctors could tell you a disease was coming years before you felt a single symptom—and stop it in its tracks? That is ...

Since President Donald Trump issued a July 2025 executive order aimed at "ending crime and disorder on America's streets," national attention has increasingly focused on involuntary treatment as a ...

Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of ...

For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such ...

Moral injury remains prevalent among critical care nurses, with newer nurses at the highest risk of developing symptoms, ...

A well-designed 10-minute online exercise can spark small reductions in depression. That's the key finding of my team's paper, published in Nature Human Behaviour.